Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ortho-hydroxybenzoic acid or derivative doai
Patent
1994-06-17
1996-05-21
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ortho-hydroxybenzoic acid or derivative doai
514166, A61K 3160, A61K 31615
Patent
active
055190146
ABSTRACT:
A medicine for treating non-inflammatory and non-infectious bowel disorders, such as irritable bowel syndrome, constipation, non-ulcer dyspepsia, gastro-oesophageal reflux with or without oesophagitis, and diverticular disease, comprising a salicylic acid derivative, such as any one of sulfasalazine, 5-aminosalicylic acid, 4-aminosalicylic acid, and benzalazine, or a combination of any two or more thereof. The treatment of those disorders comprises taking the medicine by mouth to provide a dosage rate of the salicylic acid derivative of from 200 mg to 18 g per day.
REFERENCES:
Chem. Abst. 104-39741H (1986).
Chem. Abst. 115-85417G (1991).
Chem. Abst. 116-201087W (1992).
Diseases of the Colon and rectum vol. 27, No. 8, 1984, pp. 513-514.
Gastroenterology vol. 94, No. 5, May 1988, p. A426.
LandOfFree
Treatment of non-inflammatory and non-infectious bowel disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of non-inflammatory and non-infectious bowel disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of non-inflammatory and non-infectious bowel disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2038154